{"id":"NCT04211909","sponsor":"Gilead Sciences","briefTitle":"Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection","officialTitle":"A Phase 3b Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic HCV Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-01-03","primaryCompletion":"2020-11-12","completion":"2020-11-12","firstPosted":"2019-12-26","resultsPosted":"2021-10-27","lastUpdate":"2021-10-27"},"enrollment":87,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C Virus Infection"],"interventions":[{"type":"DRUG","name":"SOF/VEL","otherNames":["Epclusa®","GS-7977/GS-5816"]},{"type":"DRUG","name":"SOF/VEL/VOX","otherNames":["Vosevi ®","GS-7977/GS-5816/GS-9857"]}],"arms":[{"label":"SOF/VEL","type":"EXPERIMENTAL"},{"label":"SOF/VEL/VOX","type":"EXPERIMENTAL"}],"summary":"The primary objectives of this study are to evaluate the antiviral efficacy, safety, and tolerability of therapy with Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC in participants with chronic HCV infection.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response (SVR) < Lower Limit of Quantification (LLOQ) 12 Weeks After Discontinuation of Study Treatment","timeFrame":"Posttreatment Week 12","effectByArm":[{"arm":"SOF/VEL","deltaMin":98.1,"sd":null},{"arm":"SOF/VEL/VOX","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"19 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":null},"locations":{"siteCount":22,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":54},"commonTop":["Headache","Nausea","Rash"]}}